Abstract
α2A-adrenoceptor (AR) is a potential target for the treatment of degenerative diseases of the central nervous system, and α2A-AR agonists are effective drugs for this condition. However, the lack of high selectivity for α2A-AR subtype of traditional drugs greatly limits their clinic usage. A series of homobivalent 4-aminoquinolines conjugated by two 4-aminoquinoline moieties via varying alkane linker length (C2-C12) were characterized for their affinities for each α2-AR subtype. Subsequently, docking, molecular dynamics and mutagenesis were applied to uncover the molecular mechanism. Most 4-aminoquinolines (4-aminoquinoline monomer, C2-C6, C8-C10) were selective for α2A-AR over α2B- and α2C-ARs. Besides, the affinities are of similar linker length-dependence for each α2-AR subtype. Among all the compounds tested, C10 has the highest affinity for α2A-AR (pKi=-7.45±0.62), which is 12-fold and 60-fold selective over α2B-AR and α2C-AR, respectively. Docking and molecular dynamics suggest that C10 simultaneously interacts with orthosteric and "allosteric" sites of the α2A-AR. The mutation of F205 decreases the affinity by 2-fold. The potential allosteric residues include S90, N93, E94 and W99. The specificity of C10 for the α2A-AR a...Continue Reading
References
Mar 12, 1992·Nature·A D FedermanH R Bourne
Aug 7, 1986·European Journal of Pharmacology·A AdamsL P Wakelin
Jan 1, 1972·Chemical & Pharmaceutical Bulletin·S M Deshpande, A K Singh
Jul 25, 1984·Nucleic Acids Research·M A LopataB Sollner-Webb
Feb 17, 2001·Molecular Pharmacology·S M WadeR R Neubig
Apr 18, 2001·Molecular Pharmacology·T NyrönenM S Johnson
May 19, 2001·Life Sciences·M ScheininA Haapalinna
Sep 13, 2003·British Journal of Pharmacology·Juha M PeltonenMika Scheinin
Nov 19, 2005·Proteins·Jean-Sebastien SurgandDidier Rognan
Feb 1, 2008·European Journal of Pharmacology·Jan HöckerBerthold Bein
Jul 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ron O DrorDavid E Shaw
Oct 19, 2011·Biochemistry·Lei ZhangRonald L Koder
Jan 27, 2012·Nature·Kazuko HagaTakuya Kobayashi
Sep 18, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Adyary FallareroPia Vuorela
May 30, 2013·British Journal of Pharmacology·A J KooistraC de Graaf
Feb 4, 2014·Psychopharmacology·Jan BrosdaHeinz H Pertz
Sep 2, 2014·Nature Reviews. Drug Discovery·P Jeffrey ConnColleen M Niswender
Dec 4, 2015·Journal of Chemical Theory and Computation·Jumin LeeWonpil Im
Mar 10, 2016·Journal of Medicinal Chemistry·Cody J LensingCarrie Haskell-Luevano
Sep 1, 2017·Frontiers in Psychiatry·Madeleine Monique UysBrian Herbert Harvey